Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors.
Chang IS, Jiang SS, Yang JC, Su WC, Chien LH, Hsiao CF, Lee JH, Chen CY, Chen CH, Chang GC, Wang Z, Lo FY, Chen KY, Wang WC, Chen YM, Huang MS, Tsai YH, Su YC, Hsieh WS, Shih WC, Shieh SH, Yang TY, Lan Q, Rothman N, Chen CJ, Chanock SJ, Yang PC, Hsiung CA.
Chang IS, et al. Among authors: lo fy.
Am J Respir Crit Care Med. 2017 Mar 1;195(5):663-673. doi: 10.1164/rccm.201602-0300OC.
Am J Respir Crit Care Med. 2017.
PMID: 27669169
Free PMC article.